BioSpace News Archive

Biotech Beach

Metacrine and Its Partners to Present Data at the EASL International Liver Congress™ 2021

Metacrine, Inc. today announced that it will present data at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2021, being held virtually from June 23-26, 2021.

June 17, 2021
·
2 min read
Drug Development

Qpex Biopharma Initiates Phase 1 Study of QPX9003 Targeting Antibiotic-Resistant Pathogens

Qpex Biopharma, Inc. announced initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic polymyxin for infections.

June 17, 2021
·
5 min read
BioMidwest

Aptinyx to Participate in Upcoming Investor Conferences - June 17, 2021

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, announced that the Company will be participating in two upcoming investor conferences

June 17, 2021
·
1 min read
Pharm Country

Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab

Amneal Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for Bevacizumab.

June 17, 2021
·
6 min read
BioCapital

Cannabics Pharmaceuticals to launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health Diseases

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the expansion of its research program with new drug development projects targeting Prostate Cancer, Neurodegenerative & Mental Health diseases.

June 17, 2021
·
5 min read
Business

ZERO – The End of Prostate Cancer and Bayer Band Together with Twisted Sister’s Jay Jay French to Raise Awareness about Prostate Cancer Screening and Treatment

ZERO and Bayer – two leaders in prostate cancer – take on one of the most common cancers in American men .

June 17, 2021
·
7 min read
FDA

Turning Point Therapeutics Granted FDA Orphan Drug Designation for TPX-0022 in Gastric Cancer

Turning Point Therapeutics, Inc. today announced that TPX-0022, the company’s inhibitor of MET has been granted orphan drug designation by the Food and Drug Administration (FDA) for the treatment of patients with gastric cancer.

June 17, 2021
·
4 min read
Biotech Bay

AcelRx Announces Agreement with FDA Addressing the Warning Letter Received for DSUVIA® Promotional Materials

AcelRx Pharmaceuticals, Inc. , today announced it has reached agreement with the Food and Drug Administration (FDA) with regards to finalizing corrective actions in a warning letter.

June 17, 2021
·
4 min read
FDA

ONWARD Receives FDA Breakthrough Device Designation for ARC-IM for Blood Pressure and Trunk Control in Spinal Cord Injury

ONWARD today announced the Company has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for their ARC-IM platform for blood pressure and trunk control in people with spinal cord injury.

June 17, 2021
·
2 min read
Business

Sectoral Asset Management Makes $9M Investment into Cagent Vascular

Cagent Vascular Inc. 1 , a developer of next generation angioplasty balloons using proprietary serration technology, announced the investment of $9M by Sectoral Asset Management.

June 17, 2021
·
3 min read